This episode examines the FDA’s premarket approval of Claire, the first AI-enabled optical coherence tomography device for intraoperative breast margin assessment, including its predetermined change control plan that decouples algorithm updates from traditional reapproval processes. We cover Philips’ Cardiac MR SmartSpeed clearance for reducing cardiac MRI scan times by up to fifty percent, Harrison.ai’s Infarct Triage software clearance for acute stroke detection, and the expansion of FDA-cleared cardiovascular AI algorithms beyond two hundred systems. The briefing details breakthrough device designation pathways now applied to acquisition quality tools, Eko’s murmur detection software, and Philips SmartHeart’s real-time cardiac structure optimization. These developments illustrate how regulatory frameworks are adapting to accommodate iterative algorithm refinement, workflow automation, and multimodal integration across imaging and point-of-care diagnostic systems.
